{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:14:55Z","timestamp":1785500095315,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/jp.2017.17","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T14:17:50Z","timestamp":1489069070000},"page":"596-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial"],"prefix":"10.1038","volume":"37","author":[{"given":"R R","family":"Malla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Asimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Teli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"BFjp201717_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0378-3782(91)90191-5","volume":"25","author":"S Shankaran","year":"1991","unstructured":"Shankaran S, Woldt E, Koepke T, Bedard MP, Nandayal R . Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev 1991; 25: 135\u2013148.","journal-title":"Early Hum Dev"},{"key":"BFjp201717_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0022-3476(89)80132-5","volume":"114","author":"CMT Robertson","year":"1989","unstructured":"Robertson CMT, Finer NN, Grace MGA . School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr 1989; 114: 753\u2013760.","journal-title":"J Pediatr"},{"key":"BFjp201717_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/jcbfm.1987.127","volume":"7","author":"R Busto","year":"1987","unstructured":"Busto R, Dietrich WD, Globus MYT, Valdes I, Scheinberg P, Ginsberg MD . Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987; 7: 729\u2013738.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFjp201717_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574\u20131584.","journal-title":"N Engl J Med"},{"key":"BFjp201717_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/archpediatrics.2011.43","volume":"165","author":"SE Jacobs","year":"2011","unstructured":"Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ . Whole body hypothermia for term and near term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med 2011; 165: 692\u2013700.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BFjp201717_CR6","doi-asserted-by":"publisher","first-page":"c363","DOI":"10.1136\/bmj.c363","volume":"340","author":"AD Edwards","year":"2010","unstructured":"Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340: c363.","journal-title":"BMJ"},{"key":"BFjp201717_CR7","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1542\/peds.2014-1566","volume":"135","author":"A Pappas","year":"2015","unstructured":"Pappas A, Shankaran S, McDonald SA, Vohr BR, Hintz SR, Ehrenkranz RA et al. Cognitive outcome after neonatal encephalopathy. Pediatrics 2015; 135: e624\u2013e638.","journal-title":"Pediatrics"},{"key":"BFjp201717_CR8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361: 1349\u20131358.","journal-title":"N Engl J Med"},{"key":"BFjp201717_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dmcn.12730","volume":"573","author":"YW Wu","year":"2015","unstructured":"Wu YW, Gonzalez FF . Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy? Dev Med Child Neurol 2015; 573: 34\u201339.","journal-title":"Dev Med Child Neurol"},{"key":"BFjp201717_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/01.STR.0000132196.49028.a4","volume":"35","author":"L Wang","year":"2004","unstructured":"Wang L, Zhang Z, Wang Y, Zhang R, Chopp M . Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004; 35: 1732\u20131737.","journal-title":"Stroke"},{"key":"BFjp201717_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00004647-199906000-00007","volume":"19","author":"M Bernaudin","year":"1999","unstructured":"Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19: 643\u2013651.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFjp201717_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.expneurol.2005.06.001","volume":"195","author":"D Mu","year":"2005","unstructured":"Mu D, Chang YS, Vexler ZS, Ferriero DM . Hypoxia-inducible factor 1 alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 2005; 195: 407\u2013415.","journal-title":"Exp Neurol"},{"key":"BFjp201717_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1203\/PDR.0b013e31819ea3b8","volume":"65","author":"I Wallach","year":"2009","unstructured":"Wallach I, Zhang J, Hartmann A, van Landeghem FK, Ivanova A, Klar M et al. Erythropoietin-receptor gene regulation in neuronal cells. Pediatr Res 2009; 65: 619\u2013624.","journal-title":"Pediatr Res"},{"key":"BFjp201717_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0168-0102(02)00161-X","volume":"44","author":"M Sugawa","year":"2002","unstructured":"Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H . Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 2002; 44: 391\u2013403.","journal-title":"Neurosci Res"},{"key":"BFjp201717_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/jnen\/60.4.386","volume":"60","author":"A Nagai","year":"2001","unstructured":"Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU . Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 2001; 60: 386\u2013392.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFjp201717_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00004647-200204000-00003","volume":"22","author":"M Bernaudin","year":"2002","unstructured":"Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P . Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002; 22: 393\u2013403.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFjp201717_CR17","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1542\/peds.2008-3553","volume":"124","author":"C Zhu","year":"2009","unstructured":"Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic- ischemic encephalopathy. Pediatrics 2009; 124: e218\u2013e226.","journal-title":"Pediatrics"},{"key":"BFjp201717_CR18","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1542\/peds.2009-2268","volume":"125","author":"H Elmahdy","year":"2010","unstructured":"Elmahdy H, El-Mashad AR, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H . Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics 2010; 125: e1135\u2013e1142.","journal-title":"Pediatrics"},{"issue":"2","key":"BFjp201717_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1542\/peds.111.2.351","volume":"111","author":"LF Shalak","year":"2003","unstructured":"Shalak LF, Laptook AR, Velaphi SC, Perlman JM . Amplitude-integrated electroencephalography coupled with an early neurologic examination enhances prediction of term infants at risk for persistent encephalopathy. Pediatrics 2003; 111 (2): 351\u2013357.","journal-title":"Pediatrics"},{"issue":"7","key":"BFjp201717_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1651-2227.1997.tb08581.x","volume":"86","author":"CM Thompson","year":"1997","unstructured":"Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, Molteno CD et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr 1997; 86 (7): 757\u2013761.","journal-title":"Acta Paediatr"},{"key":"BFjp201717_CR21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/ptj\/80.10.974","volume":"80","author":"RJ Palisano","year":"2000","unstructured":"Palisano RJ, Hanna SE, Rosenbaum PL, Russell DJ, Walter SD, Wood EP et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther 2000; 80: 974\u2013985.","journal-title":"Phys Ther"},{"key":"BFjp201717_CR22","unstructured":"Bayley N Bayley Scales of Infant Development\u2013II. Psychological Corporation: San Antonio, Texas, 1993.."},{"key":"BFjp201717_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.braindev.2010.10.014","volume":"33","author":"A Kumral","year":"2011","unstructured":"Kumral A, T\u00fcz\u00fcn F, Oner MG, Gen\u00e7 S, Duman N, Ozkan H . Erythropoietin in neonatal brain protection: the past, the present and the future. Brain Dev 2011; 33: 632\u2013643.","journal-title":"Brain Dev"},{"key":"BFjp201717_CR24","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C et al. Erythropoietin crosses the blood\u2013brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97: 10526\u201310531.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFjp201717_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000074970","volume":"85","author":"SE Juul","year":"2004","unstructured":"Juul SE, McPherson RJ, Farrell FX, Jolliffe L, Ness DJ, Gleason CA . Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate 2004; 85: 138\u2013144.","journal-title":"Biol Neonate"},{"key":"BFjp201717_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1203\/pdr.0b013e31805341dc","volume":"61","author":"PA Statler","year":"2007","unstructured":"Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE . Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 2007; 61: 671\u2013675.","journal-title":"Pediatr Res"},{"key":"BFjp201717_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000096969","volume":"91","author":"RJ McPherson","year":"2007","unstructured":"McPherson RJ, Demers EJ, Juul SE . Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 2007; 91: 36\u201343.","journal-title":"Neonatology"},{"key":"BFjp201717_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1542\/peds.2012-0498","volume":"130","author":"YW Wu","year":"2012","unstructured":"Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012; 130: 683\u2013691.","journal-title":"Pediatrics"},{"key":"BFjp201717_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1203\/01.PDR.0000163616.89767.69","volume":"58","author":"YS Chang","year":"2005","unstructured":"Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZS, McQuillen PS et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005; 58: 106\u2013111.","journal-title":"Pediatr Res"},{"key":"BFjp201717_CR30","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/brain\/awm203","volume":"130","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007; 130: 2577\u20132588.","journal-title":"Brain"},{"key":"BFjp201717_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.mp.4001907","volume":"12","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 2007; 12: 206\u2013220.","journal-title":"Mol Psychiatry"},{"key":"BFjp201717_CR32","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","volume":"40","author":"H Ehrenreich","year":"2009","unstructured":"Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K et al. Recombinant human erythropoietin in the treatment of acute ischemicstroke. Stroke 2009; 40: e647\u2013e656.","journal-title":"Stroke"},{"key":"BFjp201717_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.pediatrneurol.2014.08.010","volume":"51","author":"EE Rogers","year":"2014","unstructured":"Rogers EE, Bonifacio SL, Glass HC, Juul SE, Chang T, Mayock DE et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol 2014; 51: 657\u2013662.","journal-title":"Pediatr Neurol"},{"key":"BFjp201717_CR34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3109\/14767058.2013.855894","volume":"27","author":"MS El Shimi","year":"2014","unstructured":"El Shimi MS, Awad HA, Hassanein SM, Gad GI, Imam SS, Shaaban HA et al. Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings. J Matern Fetal Neonatal Med 2014; 27: 1295\u20131300.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"BFjp201717_CR35","doi-asserted-by":"publisher","first-page":"e20160191","DOI":"10.1542\/peds.2016-0191","volume":"137","author":"YW Wu","year":"2016","unstructured":"Wu YW, Mathur AM, Chang T, McKinstry RC, Mulkey SB, Mayock DE et al. High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a Phase II Trial. Pediatrics 2016; 137 (6): e20160191.","journal-title":"Pediatrics"},{"key":"BFjp201717_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jpeds.2013.10.084","volume":"164","author":"MJ Benders","year":"2014","unstructured":"Benders MJ, van der Aa NE, Roks M, van Straaten HL, Isgum I, Viergever MA et al. Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke. J Pediatr 2014; 164: 481\u2013486.","journal-title":"J Pediatr"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp201717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201717","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/jp.2017.17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/jp201717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:13:06Z","timestamp":1647609186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp201717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFjp201717"],"URL":"https:\/\/doi.org\/10.1038\/jp.2017.17","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]},"assertion":[{"value":"26 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}